Efficacy and safety of rovalpituzumab tesirine in patients with DLL3-expressing, ≥ 3rd line small cell lung cancer: Results from the phase 2 TRINITY study

Mapping Intimacies ◽

10.1055/s-0039-1678065 ◽

2019 ◽

Author(s):

DP Carbone ◽

D Morgensztern ◽

S Le Moulec ◽

R Santana-Davila ◽

N Ready ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung

Download Full-text

MA02.01 Efficacy and Safety of Selpercatinib in Chinese Patients With RET Fusion-Positive Non-Small Cell Lung Cancer: A Phase 2 Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.111 ◽

2021 ◽

Vol 16 (10) ◽

pp. S888-S889

Author(s):

S. Lu ◽

Y. Cheng ◽

D. Huang ◽

Y. Sun ◽

L. Wu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase 2 Trial

Download Full-text

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.08.216 ◽

2014 ◽

Vol 90 (5) ◽

pp. S37-S38 ◽

Cited By ~ 2

Author(s):

H.A. Wakelee ◽

Z. Zvirbule ◽

F. De Braud ◽

C.D. Kingsley ◽

T. Mekhail ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Controlled Study ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line

Download Full-text

Phase 2 study evaluating efficacy and safety of everolimus with letrozole in advanced (unresectable or metastatic) non-small cell lung cancer (NSCLC) after failure of platinum-based treatment: A preliminary analysis of toxicity.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e19089 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e19089-e19089

Author(s):

Sina Vatandoust ◽

Nimit Singhal ◽

Michael Paul Brown

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Preliminary Analysis ◽

Small Cell ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text

3101 Updated efficacy and safety results from a global phase 2, open-label, single-arm study (NP28673) of alectinib in crizotinib-refractory ALK+ non-small-cell lung cancer (NSCLC)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31742-7 ◽

2015 ◽

Vol 51 ◽

pp. S635 ◽

Cited By ~ 5

Author(s):

F. Barlesi ◽

A.M.C. Dingemans ◽

I. Ou ◽

J.S. Ahn ◽

L.D. Petris ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Open Label

Download Full-text

Efficacy and safety of lurbinectedin (PM1183) in small cell lung cancer (SCLC): Results from a phase 2 study.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.8570 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 8570-8570 ◽

Cited By ~ 7

Author(s):

Jose Manuel Trigo Perez ◽

Alexandra Leary ◽

Benjamin Besse ◽

Daniel E. Castellano ◽

Santiago Ponce Aix ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text

Brigatinib (BRG) in Crizotinib (CRZ)-Refractory ALK+ Non–Small Cell Lung Cancer (NSCLC): efficacy and safety results from ALTA, a pivotal randomized phase 2 Trial

Annals of Oncology ◽

10.1093/annonc/mdw332.04 ◽

2016 ◽

Vol 27 ◽

pp. iv4

Author(s):

D. Kim ◽

M. Tiseo ◽

M. Ahn ◽

K. Reckamp ◽

K. Holmskov Hansen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial

Annals of Palliative Medicine ◽

10.21037/apm-21-443 ◽

2021 ◽

Vol 10 (3) ◽

pp. 3277-3285

Author(s):

Yi Zhao ◽

Xu Zhang ◽

Chenxing Jin ◽

Xiaomin Yu ◽

Min Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Open Label ◽

Open Label Trial

Download Full-text

Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer withFGFR1amplification: A single-arm, phase 2 study

Cancer ◽

10.1002/cncr.30135 ◽

2016 ◽

Vol 122 (19) ◽

pp. 3024-3031 ◽

Cited By ~ 37

Author(s):

Sung Hee Lim ◽

Jong-Mu Sun ◽

Yoon-La Choi ◽

Hye Ryun Kim ◽

Soomin Ahn ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase 2 Study ◽

Pretreated Patients

Download Full-text

MA07.02 Updated Efficacy and Safety Data from the Phase 2 NP28761 Study of Alectinib in ALK-Positive Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.426 ◽

2017 ◽

Vol 12 (1) ◽

pp. S378 ◽

Cited By ~ 5

Author(s):

D. Ross Camidge ◽

Shirish Gadgeel ◽

Sai-Hong Ou ◽

Leena Gandhi ◽

Gregory Riely ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Safety Data ◽

Small Cell ◽

Phase 2 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Alk Positive

Download Full-text